Healthcare - Biotechnology - NASDAQ - US
$ 2.53
-6.3 %
$ 179 M
Market Cap
-1.38
P/E
BALANCE SHEET
379 M
ASSETS
106 M
LIABILITIES
273 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Nkarta, Inc.
| Current Assets | 253 M |
| Cash & Short-Term Investments | 248 M |
| Receivables | 0 |
| Other Current Assets | 4.88 M |
| Non-Current Assets | 126 M |
| Long-Term Investments | 0 |
| PP&E | 119 M |
| Other Non-Current Assets | 6.54 M |
| Current Liabilities | 23.3 M |
| Accounts Payable | 3.66 M |
| Short-Term Debt | 12.1 M |
| Other Current Liabilities | 7.53 M |
| Non-Current Liabilities | 82.3 M |
| Long-Term Debt | 82.3 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 31.0 | 37.5 | 60.8 | 96.7 | 20.6 | 7.9 |
| Short Term Investments | 217.1 | 314.6 | 177.3 | 218.2 | 16.4 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0.1 |
| Inventory | 0 | (4.2) | 0 | 0 | 0 | 0.1 |
| Other Current Assets | 4.9 | 8.5 | 7.7 | 3.9 | 0.5 | 0.2 |
| Total Current Assets | 253.1 | 354.9 | 240.2 | 315.3 | 37.5 | 8.2 |
| PP&E | 119.3 | 107.7 | 24.5 | 17.9 | 10.2 | 1.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 2.7 | 2.1 | 0.4 | 0.3 | 89.8 K |
| Other Long Term Assets | 6.5 | 7.7 | 7.1 | 4.1 | 0.5 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 378.9 | 472.9 | 273.9 | 337.6 | 48.4 | 9.6 |
| LIABILITIES | ||||||
| Accounts Payable | 3.7 | 1.8 | 1.1 | 1.2 | 1.9 | 0.4 |
| Short Term Debt | 12.1 | 8.5 | 5.0 | 2.8 | 1.5 | 0 |
| Other Current Liabilities | 7.5 | 11.8 | 6.9 | 4.9 | 4.8 | 1.7 |
| Total Current Liabilities | 23.3 | 17.8 | 10.5 | 7.5 | 8.2 | 2.1 |
| Long Term Debt | 82.3 | 78.7 | 10.0 | 7.5 | 5.8 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 0 | 18 K | 82 K | 59.9 | 12.9 |
| Total Liabilities | 105.6 | 100.7 | 22.9 | 16.4 | 73.9 | 15.0 |
| EQUITY | ||||||
| Common Stock | 5 K | 5 K | 3 K | 3 K | 160 | 123 |
| Retained Earnings | (435.4) | (317.9) | (204.1) | (118.0) | (26.7) | (5.6) |
| Other Accumulative Comprehensive Income/Loss | 8 K | (0.7) | (0.1) | 3 K | 2.14 K | (0.2) |
| Total Equity | 273.3 | 372.2 | 251.0 | 321.2 | (25.5) | (5.4) |
| Total Liabilities and Equity | 378.9 | 472.9 | 273.9 | 337.6 | 48.4 | 9.6 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 49.0 | 43.6 | 32.9 | 31.8 | 9.0 | 5 027.0 |